PERIPHERAL BLOOD STEM CELL TRANSPLANTATION

Clinical trials for PERIPHERAL BLOOD STEM CELL TRANSPLANTATION explained in plain language.

Never miss a new study

Get alerted when new PERIPHERAL BLOOD STEM CELL TRANSPLANTATION trials appear

Sign up with your email to follow new studies for PERIPHERAL BLOOD STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a lower dose of a harsh transplant drug be the key to fewer complications?

Disease control Recruiting now

This study aims to find the lowest effective dose of a drug called cyclophosphamide, given after a stem cell transplant, to prevent a serious complication called graft-versus-host disease (GVHD). The goal is to reduce the drug's own side effects while still protecting patients. I…

Matched conditions: PERIPHERAL BLOOD STEM CELL TRANSPLANTATION

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

PERIPHERAL BLOOD STEM CELL TRANSPLANTATION

Get alerted when new PERIPHERAL BLOOD STEM CELL TRANSPLANTATION trials appear

Could a lower dose of a harsh transplant drug be the key to fewer complications?